60687-765-13 : NDC 2026 Code

60687-765-13 : Valganciclovir Hydrochloride ( Valganciclovir )

Additionally :

You can get information about “60687-765-13” NDC code in 60687-765-13 in HTML format

HTML | 60687-765-13 in TXT (Plain Text) format

TXT | 60687-765-13 in PDF (Portable Document Format)

PDF | 60687-765-13 in XML format

XML formats.

NDC Code : 60687-765-13 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "60687-765-13",
    "PackageDescription": "1 BOTTLE, GLASS in 1 CARTON (60687-765-13)  / 100 mL in 1 BOTTLE, GLASS",
    "NDC11Code": "60687-0765-13",
    "ProductNDC": "60687-765",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Valganciclovir",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Valganciclovir Hydrochloride",
    "DosageFormName": "POWDER, FOR SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20230820",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA211475",
    "LabelerName": "American Health Packaging",
    "SubstanceName": "VALGANCICLOVIR HYDROCHLORIDE",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2023-08-24",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230820",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}